ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,10179
0,58%
Bitcoin
63.979,47
0,14%
Brent Oil
83,225
0,56%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Erytech Pharma SA (ERYP)

  7. Erytech Pharma SA (ERYP) Notícias

ERYP

Erytech Pharma (ERYP)

Erytech Pharma SA
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ERYP
DataHoraFonteTítuloCódigoCompanhia
30/06/202312:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ERYPErytech Pharma SA
29/06/202316:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ERYPErytech Pharma SA
29/06/202316:52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ERYPErytech Pharma SA
28/06/202309:54Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ERYPErytech Pharma SA
24/05/202317:52Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:ERYPErytech Pharma SA
09/05/202311:30AllPennyStocks.comMicro Cap Bid Up Right Before Opening BellNASDAQ:ERYPErytech Pharma SA
14/02/202314:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ERYPErytech Pharma SA
25/08/202214:21Dow Jones NewsErytech Pharma Shares Hit 52-Week Low After Ending Plans for License Application for GraspaNASDAQ:ERYPErytech Pharma SA
27/04/202213:51Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ERYPErytech Pharma SA
15/02/202208:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ERYPErytech Pharma SA
21/09/202113:51Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ERYPErytech Pharma SA
07/05/202117:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ERYPErytech Pharma SA
05/05/202117:51Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ERYPErytech Pharma SA
29/01/202118:37Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ERYPErytech Pharma SA
13/10/202007:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ERYPErytech Pharma SA
08/10/202018:24Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:ERYPErytech Pharma SA
22/09/202007:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ERYPErytech Pharma SA
14/09/202013:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2020NASDAQ:ERYPErytech Pharma SA
06/08/202013:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2020NASDAQ:ERYPErytech Pharma SA
10/07/202013:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020NASDAQ:ERYPErytech Pharma SA
09/06/202013:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 30, 2020NASDAQ:ERYPErytech Pharma SA
07/05/202013:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2020NASDAQ:ERYPErytech Pharma SA
06/04/202013:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2020NASDAQ:ERYPErytech Pharma SA
06/03/202014:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – February 29, 2020NASDAQ:ERYPErytech Pharma SA
04/02/202014:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2020NASDAQ:ERYPErytech Pharma SA
10/01/202013:45GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2019NASDAQ:ERYPErytech Pharma SA
02/12/201914:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2019NASDAQ:ERYPErytech Pharma SA
05/11/201919:00GlobeNewswire Inc.ERYTECH to Host Third Quarter 2019 Conference Call and Business Update on November 8, 2019NASDAQ:ERYPErytech Pharma SA
05/11/201914:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2019NASDAQ:ERYPErytech Pharma SA
04/10/201913:00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2019NASDAQ:ERYPErytech Pharma SA
 Apresentando as notícias mais relevantes sobre:NASDAQ:ERYP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
HETA4
HERCULES PN
BOV
AZUL4
AZUL PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados